We therefore utilized Mendelian randomization to assess whether the relevance between circulating IL-6 and cancer is causal by selecting the most frequently evaluated variant -174G/C in IL-6 gene as a genetic instrument to minimize residual confounding and reverse causation. Here, IL6 is linked to cancer.